课题基金 / 基金详情

The impact of cotrimoxazole prophylaxis in HIV-infected children on antimicrobial resistance gene carriage in the fecal microbiome.

The impact of cotrimoxazole prophylaxis in HIV-infected children on antimicrobial resistance gene carriage in the fecal microbiome.
HIV感染儿童预防性使用复方新诺明对粪便微生物组中抗菌素耐药性基因携带的影响。
批准号：
406327
负责人：
Francis Abelanjo Freddy
金额：
$1.27万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-12-01 至 2019-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=406327&lang=en
关键词：
Antibiotic Prophylaxis Antimicrobial Resistance Antimicrobial Stewardship Co-Resistance Endemic Resistance Gut Flora Hiv Therapy Microbiome Multi-Drug-Resistant Organisms Risk Of Resistance

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The immune system is the body’s defence against invading pathogens. Human immunodeficiency virus (HIV) interferes with the normal functioning of the immune system, thereby increasing the chances of infection. Antibiotics have primarily been used to treat
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金